These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30384338)

  • 21. A needle-free reconstitution and transfer system for compounded sterile intravenous drug solutions in compliance with United States Pharmacopeia Chapter <797> standards.
    Marks Z
    Int J Pharm Compd; 2014; 18(2):94-9. PubMed ID: 24881111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality Control and Basics of Sterile Compounding: Attempting to Avoid Out-of-Specification Results and Patient Harm in Sterile Compounding.
    Martin M
    Int J Pharm Compd; 2019; 23(1):47-49. PubMed ID: 30668535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implementing United States Pharmacopeia Chapter <1163>. Quality assurance in pharmaceutical compounding, Part 3: Testing.
    Allen LV
    Int J Pharm Compd; 2012; 16(4):322-8. PubMed ID: 23050393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. United States Parmacopeia Chapter <797> timeline: 1989 to 2013.
    Newton DW
    Int J Pharm Compd; 2013; 17(4):283-8. PubMed ID: 24261142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does your pharmacy have a compounding isolator?
    LaBella CJ
    Am J Health Syst Pharm; 2007 Apr; 64(8):855-8. PubMed ID: 17420203
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of various requirements of the quality assurance procedures for (18)F-FDG injection.
    Hung JC
    J Nucl Med; 2002 Nov; 43(11):1495-506. PubMed ID: 12411554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The essentials of United States Pharmacopeia Chapter <51> antimicrobial effectiveness testing and its application in pharmaceutical compounding.
    Vu N; Nguyen K; Kupiec TC
    Int J Pharm Compd; 2014; 18(2):123-30. PubMed ID: 24881116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. USP chapter 797: establishing a practice standard for compounding sterile preparations in pharmacy.
    Kastango ES; Bradshaw BD
    Am J Health Syst Pharm; 2004 Sep; 61(18):1928-38. PubMed ID: 15487884
    [No Abstract]   [Full Text] [Related]  

  • 29. Misinterpretations of United States pharmacopeia chapter <797>.
    McElhiney LF
    Int J Pharm Compd; 2012; 16(1):6-10. PubMed ID: 23050305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. End-preparation assessments and tests for compounded sterile preparations.
    McElhiney LF
    Int J Pharm Compd; 2013; 17(4):307-11. PubMed ID: 24261146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of risk for sterile preparations.
    ben-Horin SF; Rousso T
    Int J Pharm Compd; 2014; 18(1):30-4. PubMed ID: 24881337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decontamination technology: the missing element.
    Rahe H
    Int J Pharm Compd; 2013; 17(3):193-9. PubMed ID: 24046934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sterility of extemporaneously compounded preservative-free injections.
    Levchuk JW
    Am J Hosp Pharm; 1991 Jan; 48(1):71-2. PubMed ID: 2053941
    [No Abstract]   [Full Text] [Related]  

  • 34. Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding.
    Ligugnana R
    Int J Pharm Compd; 2017; 21(3):182-190. PubMed ID: 28557779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Draft guidelines on quality assurance for pharmacy-prepared sterile products.
    Am J Hosp Pharm; 1992 Feb; 49(2):407-17. PubMed ID: 1554008
    [No Abstract]   [Full Text] [Related]  

  • 36. Revisions continue on USP sterile-compounding chapter.
    Thompson CA
    Am J Health Syst Pharm; 2005 Sep; 62(18):1856, 1858, 1861-2. PubMed ID: 16141100
    [No Abstract]   [Full Text] [Related]  

  • 37. Implementing United States Pharmacopeia Chapter <1163>: Quality assurance in pharmaceutical compounding, part 4: cleaning and packaging.
    Allen LV
    Int J Pharm Compd; 2012; 16(5):405-14. PubMed ID: 23072201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Automated endotoxin testing program for high-risk-level compounded sterile preparations at an institutional compounding pharmacy.
    Cooper JF; Latta KS; Smith D
    Am J Health Syst Pharm; 2010 Feb; 67(4):280-6. PubMed ID: 20133532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compounding pharmacy conundrum: "we cannot live without them but we cannot live with them" according to the present paradigm.
    Guharoy R; Noviasky J; Haydar Z; Fakih MG; Hartman C
    Chest; 2013 Apr; 143(4):896-900. PubMed ID: 23412546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A collaborative effort to comply with USP chapter 797 for compounding sterile preparations for investigational use.
    Formea CM; Weiss WT; McCluskey SV
    Am J Health Syst Pharm; 2008 Jul; 65(13):1266-9. PubMed ID: 18574018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.